Grant: Team Grant: Health Effects of Ultra-Processed Foods-Mechanisms of Health Eff-LOI
McMaster University
$10,000.00
Understanding mechanisms underlying chronic intestinal inflammation mediated by Ultra-Processed Foods
FY 2025-26
Summary
Chronic bowel diseases, including inflammatory bowel disease (IBD) and celiac disease (CeD), are becoming increasingly common worldwide. These incurable conditions often cause persistent symptoms, complications, and high healthcare costs. People living with these diseases rely heavily on diet to manage symptoms and maintain quality of life. Ultra-Processed Foods (UPF) such as dyes, additives, ready-to-eat meals, and many gluten-free products, now make up a large portion of modern diets. Their rising consumption parallels the increase in IBD and CeD, and studies, including our own, suggest that UPF is linked to an elevated risk of developing IBD and to metabolic complications after diagnosis. Our preclinical studies have also shown that food dyes and caking agents worsen intestinal inflammation and CeD in well-characterized mouse models.
We believe that UPF worsen chronic intestinal diseases and related health problems by disrupting the gut barrier and triggering inflammation. The main goals of our project are to: (1) examine UPF intake in people with IBD and CeD, and (2) understand how synthetic and artificial components of UPF contribute to gut inflammation and gluten sensitivity.
In Aim 1, we will determine whether specific types of UPF are associated with persistent symptoms, intestinal inflammation, related health problems, and changes in gut bacteria using our unique, well-characterized clinical cohorts. In Aim 2, we will use human mini-gut models and validated animal models to investigate how specific food additives affect the gut lining and immune responses in validated models.
By identifying how UPF contribute to intestinal inflammation and disease complications, and why some individuals may be more susceptible, this research will provide critical evidence to guide dietary recommendations. Ultimately, it has the potential to improve patient outcomes, reduce healthcare costs, and raise awareness of how modern diets affect gut health.
Department
Program
Team Grant: Health Effects of Ultra-Processed Foods-Mechanisms of Health Eff-LOI
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
574979
Name
Moayyedi Paul
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Health Effects of Ultra-Processed Foods - LOI
Projecttitle
Understanding mechanisms underlying chronic intestinal inflammation mediated by Ultra-Processed Foods
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Team Grant: Health Effects of Ultra-Processed Foods-Mechanisms of Health Eff-LOI
Keyworddelim
Celiac Disease; Chronic Intestinal Disorders; Diet; Inflammatory Bowel Disease; Microbiome
Abstract
Chronic bowel diseases, including inflammatory bowel disease (IBD) and celiac disease (CeD), are becoming increasingly common worldwide. These incurable conditions often cause persistent symptoms, complications, and high healthcare costs. People living with these diseases rely heavily on diet to manage symptoms and maintain quality of life. Ultra-Processed Foods (UPF) such as dyes, additives, ready-to-eat meals, and many gluten-free products, now make up a large portion of modern diets. Their rising consumption parallels the increase in IBD and CeD, and studies, including our own, suggest that UPF is linked to an elevated risk of developing IBD and to metabolic complications after diagnosis. Our preclinical studies have also shown that food dyes and caking agents worsen intestinal inflammation and CeD in well-characterized mouse models.
We believe that UPF worsen chronic intestinal diseases and related health problems by disrupting the gut barrier and triggering inflammation. The main goals of our project are to: (1) examine UPF intake in people with IBD and CeD, and (2) understand how synthetic and artificial components of UPF contribute to gut inflammation and gluten sensitivity.
In Aim 1, we will determine whether specific types of UPF are associated with persistent symptoms, intestinal inflammation, related health problems, and changes in gut bacteria using our unique, well-characterized clinical cohorts. In Aim 2, we will use human mini-gut models and validated animal models to investigate how specific food additives affect the gut lining and immune responses in validated models.
By identifying how UPF contribute to intestinal inflammation and disease complications, and why some individuals may be more susceptible, this research will provide critical evidence to guide dietary recommendations. Ultimately, it has the potential to improve patient outcomes, reduce healthcare costs, and raise awareness of how modern diets affect gut health.
Competitiondate
202601
Approvedterm2
1 yr 0 mth
Pinamesdelim
Moayyedi, Paul; Caminero Fernández, Alberto; Khan, Waliul I; Verdu, Elena F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~